Diagnostics

Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer

Results from DENALI Part 1b show an Objective Response Rate (ORR) of ~35% in response-evaluable, heavily-pretreated patients with Cyclin E1+...

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader

Advances radiopharmaceutical leadership with addition of scalable manufacturing infrastructure and end-to-end clinical development capabilities Adds OCTEVY™, a registrational-stage diagnostic asset,...

Intelligent Bio Solutions Partners with IVY Diagnostics to Expand in Europe’s $3.6 Billion Drug Screening Market and in Middle Eastern Regions

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical...

Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell

GOLETA, Calif.--(BUSINESS WIRE)--$INGN #AirwayClearance--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare...

Covetrus Continues to Transform the Animal Healthcare Industry as It Advances the Covetrus Platform™ in Support of Veterinarian Clinics Across the U.S.

Innovative Platform combined with the VetSuite network is empowering veterinarians to significantly improve financial and clinical outcomes PORTLAND, Maine, Jan....

Next-Generation Sequencing Services Market Poised for Remarkable Growth: Projected to Increase from $7 Billion in 2024 to $15 Billion by 2031: – Market Research Intellect

The Next-Generation Sequencing (NGS) Services Market is driven by several key factors, including significant advancements in sequencing technologies that enhance...

error: Content is protected !!